HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,628,160 | +1.3% | 238,812 | -10.0% | 1.37% | +50.2% |
| Q2 2023 | $27,275,923 | +13.1% | 265,201 | +20.0% | 0.91% | +13.6% |
| Q1 2023 | $24,119,940 | +84.3% | 221,000 | +92.2% | 0.80% | +25.5% |
| Q4 2022 | $13,087,000 | -10.1% | 115,000 | -16.9% | 0.64% | +18.1% |
| Q1 2022 | $14,555,000 | -1.4% | 138,341 | +1.0% | 0.54% | -16.6% |
| Q4 2021 | $14,765,000 | -10.9% | 137,018 | -9.4% | 0.65% | -20.0% |
| Q3 2021 | $16,566,000 | +23.2% | 151,235 | +5.3% | 0.81% | +29.1% |
| Q2 2021 | $13,450,000 | +1051.5% | 143,630 | +1031.4% | 0.63% | +784.5% |
| Q1 2021 | $1,168,000 | -81.3% | 12,695 | -84.2% | 0.07% | -87.1% |
| Q3 2020 | $6,261,000 | -2.3% | 80,595 | -30.1% | 0.55% | -25.3% |
| Q2 2020 | $6,409,000 | +45.4% | 115,318 | -22.5% | 0.74% | -25.1% |
| Q1 2020 | $4,409,000 | -34.2% | 148,836 | -19.5% | 0.98% | +40.1% |
| Q4 2019 | $6,697,000 | – | 185,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |